News

BioSig to Highlight New Data from the PURE EP™ Platform at Heart Rhythm 2023

Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP™ PlatformWestport, CT,…

1 year ago

Microbot Medical’s LIBERTY® Robotic System Surpasses 100th Catheterization

95% success rate of reaching pre-determined vascular target with no intraoperative complications presented during pre-clinical studiesHINGHAM, Mass., May 03, 2023…

1 year ago

Neuronetics Showcases New NeuroStar® TMS Findings at Clinical TMS Society Annual Meeting

Data highlights the Company’s commitment to advancing TMS and improving patient outcomesMALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics,…

1 year ago

Cannabix Technologies Files Contact-Free Breath Patent Application and Updates on Development and Certification Plans

Cannabix has developed a contactless alcohol breathalyzer for employers and vehicles Cannabix Technologies Inc. Cannabix Contactless Alcohol Breathalyzer (Wall and…

1 year ago

Newsight Imaging and Brightlaser Awarded Collaboration Grant to Develop Next Generation 3D Home and Industrial Security LiDAR

Grant is the First Funding from the Hong Kong-Israel R&D Cooperation Programme3D LiDAR Camera will Combine Newsight’s eTOFTM Proprietary Patented…

1 year ago

Femasys’ FemCerv Endocervical Tissue Sampler for Cervical Cancer Diagnosis Receives Product Approval in Canada

- FemCerv® is the first endocervical tissue sampler designed to collect and contain a comprehensive sample to maximize quality and…

1 year ago

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, May 03, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel…

1 year ago

Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence Technologies

DEERFIELD, Ill., May 03, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on…

1 year ago

Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023

HOUSTON, May 03, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a leading T-cell receptor…

1 year ago

Veru Enters into Common Stock Purchase Agreement for Up to $100 Million with Lincoln Park Capital

MIAMI, FL, May 03, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

1 year ago